Le May Sylvie, Wu Wenjia, Francoeur Maxime, Dodin Philippe, Doyon-Trottier Evelyne, Hung Nicole, Guingo Estelle, Vu An Kateri, Sylfra Annie, Lessard Laurence, Cara-Slavich Stephany, DeKoven Kathryn
Institut TransMedTech, CHU Sainte-Justine Research Center, Montreal, QC, Canada.
Faculty of Nursing, University of Montreal, Montreal, QC, Canada.
Front Pain Res (Lausanne). 2024 Jan 8;4:1350578. doi: 10.3389/fpain.2023.1350578. eCollection 2023.
Healthcare professionals (HCP) perform various needle procedures that can be distressing and painful for children and adults. Even though many strategies have been proven effective in reducing distress and pain, topical anesthetic use before needle procedures is uncommon. However, there are limited studies in the existing literature comparing specifically liposomal lidocaine and tetracaine hydrochloride topical creams.
This systematic review analyzed studies on the use of two anesthetic creams, Liposomal Lidocaine (Maxilene®) and Tetracaine hydrochloride (Ametop™), in children and adults undergoing a needle-related procedure. Databases searched: PubMed, CINAHL, ClinicalTrials. Only randomized controlled trials (RCT) and Controlled Clinical Trials (CCT) studies were included. Cochrane Collaboration's Risk of Bias assessment tool was used. Strictly minimally invasive procedures were included to standardize different skin needle interventions.
Only one study with 60 participants was available to be included in this review. No statistically significant difference was found in the mean pain score among both interventions. The outcomes of self-reported distress during cannulation and on HCP satisfaction were not reported. However, physiological characteristics associated with stress/anxiety and on cannulation success rate were reported and did not show statistical significance.
Little to no evidence regarding the most efficient cream between liposomal lidocaine and tetracaine hydrochloride for pain management during needle-related procedures was found. Further studies, particularly RCT with larger sample sizes and standardized outcome measures, are needed to confirm the relative efficacy of either anesthetic cream.
医护人员会实施各种注射操作,这对儿童和成人来说可能会造成困扰和疼痛。尽管已证实许多策略在减轻困扰和疼痛方面有效,但在注射操作前使用局部麻醉剂的情况并不常见。然而,现有文献中比较脂质体利多卡因和盐酸丁卡因局部乳膏的研究有限。
本系统评价分析了在接受注射相关操作的儿童和成人中使用两种麻醉乳膏(脂质体利多卡因(Maxilene®)和盐酸丁卡因(Ametop™))的研究。检索的数据库:PubMed、CINAHL、临床试验。仅纳入随机对照试验(RCT)和对照临床试验(CCT)研究。使用了Cochrane协作网的偏倚风险评估工具。纳入严格的微创手术以规范不同的皮肤注射干预措施。
本评价仅纳入了一项有60名参与者的研究。两种干预措施的平均疼痛评分未发现统计学显著差异。未报告插管过程中自我报告的困扰结果以及医护人员的满意度。然而,报告了与压力/焦虑相关的生理特征以及插管成功率,且未显示出统计学显著性。
关于脂质体利多卡因和盐酸丁卡因在注射相关操作疼痛管理方面哪种乳膏最有效的证据很少或几乎没有。需要进一步的研究,特别是样本量更大且有标准化结局指标的随机对照试验,以确认两种麻醉乳膏的相对疗效。